Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Our providers will monitor your progress and manage any potential side effects (such as nausea or digestive discomfort), and adjust your treatment as needed for your safety and success
Why clinical trial data has limitations Clinical trials provide valuable data, but they do not tell the complete story
Diabetes Care 43 , 634642 (2020)
At the center of the websitehighlighted on the front pageare popular GLP-1 weight loss medications, including Wegovy, Zepbound and Ozempic
Beginning July 1, 2026, the Medicare GLP-1 Bridge Program may allow eligible Medicare Part D patients to access certain obesity-indicated GLP-1 medications, including Foundayo, Wegovy, and certain Zepbound formulations, for no more than $50 per month through December 31, 2027
US$ 24.84
US$ 23.59
US$ 23.34
US$ 28.17
